Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined integrin αvβ3 and lactoferrin receptor targeted docetaxel liposomes enhance the brain targeting effect and anti-glioma effect
Na Qi, Shangqian Zhang, Xiantai Zhou, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Encapsulation of Au(III) Complex Using Lactoferrin Nanoparticles to Combat Glioma
Juzheng Zhang, Ronghao Fang, Yanping Li, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 7, pp. 3632-3644
Closed Access | Times Cited: 8
A novel active mitochondrion-selective fluorescent probe for the NIR fluorescence imaging and targeted photodynamic therapy of gastric cancer
Jie Ding, Xing Kang, Min Feng, et al.
Biomaterials Science (2022) Vol. 10, Iss. 17, pp. 4756-4763
Closed Access | Times Cited: 12
Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells
Yongyan Wu, Yufeng Qian, Wei Peng, et al.
PeerJ (2023) Vol. 11, pp. e15571-e15571
Open Access | Times Cited: 6
Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects
Manasa Manjunath Hegde, Puja Sandbhor, J Aishwarya, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
An Overview of Nanotherapeutic Drug Delivery Options for the Management of Glioblastoma
William Pentz, Vincenzo J. Pizzuti, Matthew Halbert, et al.
Journal of Nanotheranostics (2023) Vol. 4, Iss. 3, pp. 323-345
Open Access | Times Cited: 5
Sensitizing chemotherapy for glioma with fisetin mediated by a microenvironment-responsive nano-drug delivery system
Wan-Yu Wang, Yuanyuan Zhang, Yue Jian, et al.
Nanoscale (2023) Vol. 16, Iss. 1, pp. 97-109
Open Access | Times Cited: 5
Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model
Na Qi, Xiantai Zhou, Ningzhu Ma, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3071-3086
Open Access | Times Cited: 1
An Insight into Fisetin, The Miraculous Multifaceted Flavonol: Paving the Road for Enhanced Delivery Through Promising Pharmaceutical Nano-Formulations.
Asmaa H. Elwan, Soha M. El-Masry, Doaa A. Habib, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106292-106292
Closed Access | Times Cited: 1
Fabrication, characterization, and in vitro biological evaluation of glycyrrhetinic acid ligand-functionalized proliposomes encapsulated docetaxel for treatment of hepatocellular carcinoma
Lin Yuan, Chuangnan Li, Kaijie Cen, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024), pp. 135802-135802
Closed Access | Times Cited: 1
Encapsulation of paclitaxel into date palm lipid droplets for enhanced brain cancer therapy
Amal Yousfan, Nour Moursel, Abdulsamie Hanano
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma
Hongyan Cui, Liuwei Zhang, Shuang Zeng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 27, pp. 30493-30506
Closed Access | Times Cited: 6
Smart Advancements for Targeting Solid Tumors via Protein and Peptide Drug Delivery (PPD)
Siddharth Singh, Priyanka Sanwal, Samir Bhargava, et al.
Current Drug Delivery (2022) Vol. 20, Iss. 6, pp. 669-682
Closed Access | Times Cited: 4
Advances in tumor stroma-based targeted delivery
Chunyan Wu, Yujia Zhai, Jianbo Ji, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124580-124580
Closed Access
Bromocriptine mesylate-loaded nanoparticles co-modified with low molecular weight protamine and lactoferrin for enhanced nose-to-brain delivery in Parkinson’s disease treatment
Huijing Cong, Jing Hu, Jing Wang, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125054-125054
Closed Access
Enhanced anti-glioma efficacy of biodegradable periodic mesoporous organosilica nanoparticles through target delivery of chemotherapeutics
Min Dong, Ying Liu, Biao Liu, et al.
Journal of Materials Science Materials in Medicine (2023) Vol. 34, Iss. 10
Open Access | Times Cited: 1
HucMSCs-derived Exosomes Protect Against 6-hydroxydopamine-induced Parkinson’s Disease in Rats by Inhibiting Caspase-3 Expression and Suppressing Apoptosis
Hong‐Xu Chen, Hongjun Xu, Wang Zhang, et al.
Current Stem Cell Research & Therapy (2024) Vol. 20, Iss. 3, pp. 266-278
Closed Access
In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles
Dan Yun, Dengyuan Liu, Jinlin Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2644-2644
Open Access
Previous Page - Page 2

Scroll to top